PDL1 expression predicts therapeutic outcome in non metastatic anal squamous cell carcinoma (NMASCC).

Iseas, IS; Golubicki, M; Robbio, J; Ruiz, G; Salanova, R; Mariani, J; Slutsky, E; Vecchioni, D; Oviedo, A; Guerra, F; Maquieira, J; Basilletti, J; Picconi, A; Roca, E; Mendez, G; Coraglio, M

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):